Professor Kari Remes - UTU Research Portal

Kari Remes
Professor

- Docent,
Faculty of Medicine (University of Turku)

kari.remes@utu.fi

	Publications full list.pdf
	CV Remes Kari.pdf

Clinical haematology; Bone marrow transplantation

Hematologian luennointi ja seminaarit (C6 ja C11). Hematologian ryhmäopetus (C6). Hematologisten syventävien opinnäytteiden ohjaus.

4 of 6

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma (2014)
- Blood Cancer Journal
R Silvennoinen, T Lundan, V Kairisto, T-T Pelliniemi, M Putkonen, P Anttila, V Huotari, P Mäntymaa, S Siitonen, L Uotila, T-L Penttilä, V Juvonen, T Selander, K Remes
Fidaxomicin treatment for Clostridium difficile in allogeneic transplant recipients (2014)
- Bone Marrow Transplantation
T. Salmi, J. Oksi, U. Salmenniemi, M. Putkonen, M. Kauppila, M. Oksman, K. Remes, M. Itälä-Remes
Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response (2014)
- European Journal of Haematology
Koskenvesa P., Kreutzman A., Rohon P., Pihlman M., Vakkila E., Räsänen A., Vapaatalo M., Remes K., Lundán T., Hjorth-Hansen H., Vakkila J., Simonsson B., Mustjoki S., Porkka K
Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-Up of a Randomized Study (2014)
- Biology of Blood and Marrow Transplantation
Tapani Ruutu, Eeva Juvonen, Mats Remberger, Kari Remes, Liisa Volin, Jonas Mattsson, Anne Nihtinen, Hans Hägglund, Olle Ringdén; on behalf of the Nordic Group for Blood and Marrow Transplantation
Leukemioiden hoito muuttuu yhä räätälöidymmäksi (2014)
- Mediuutiset
Kari Remes
Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients (2013)
- British Journal of Haematology
Silvennoinen R, Kairisto V, Pelliniemi TT, Putkonen M, Anttila P, Saily M, Sikio A, Opas J, Penttila K, Kuittinen T, Honkanen T, Lundan T, Juvonen V, Luukkaala T, Remes K
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma – a Nordic Myeloma Study Group randomized phase 3 trial (2013)
- Blood
Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukas E, Carlson K, Kvam AK, Nahi H, Lindas R, Andersen NF, Turesson I, Waage A, Westin J, for the Nordic Myeloma Study Group
Outcome of allogeneic SCT in patients with pre-transplant invasive fungal infection (2013)
- Bone Marrow Transplantation
Salmenniemi U, Remes K, Itälä-Remes M
Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation (2013)
- European Journal of Haematology
Virtanen JM, Itälä-Remes MA, Remes KJ, Vahlberg T, Saunavaara JP, Sinisalo M, Parkkola RK
Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter´s syndrome) (2012)
- Journal of Clinical Oncology
Cwymarski K, van Biezen A, de Wreede L, Stilgenbauer S, Bunjes D, Metzner B, Koza V, Mohty M, Remes K, Russell N, Nagler A, Scholten M, de Witte T, Sureda N, Dreger P